According to FutureWise analysis the market for assisted reproductive technology in 2023 was US$ 28.55 billion, and is expected to reach US$ 55.31 billion by 2031 at a CAGR of 8.60%.

Assisted Reproductive Technology (ART) plays a significant role in addressing infertility issues. This approach involves various fertility procedures that are focused on both eggs and sperm. The process usually starts with retrieving eggs from the ovaries, which are subsequently mixed with sperm to form embryos. These embryos are subsequently transferred back into the bodies of the prospective parents.Among the different assisted reproductive technologies (ART), in vitro fertilization (IVF) stands out as the most commonly used and effective method.

ART procedures can involve the use of donor eggs, donor sperm, or frozen embryos. Additionally, the use of gestational carriers or surrogates may be considered. A surrogate refers to a woman who carries and gives birth to a child using sperm from one partner, while a gestational carrier carries a child conceived from an egg and sperm from both partners.

The prevalence of multiple pregnancies is a common consequence associated with ART. While most individuals pursue ART primarily to overcome infertility, some may also seek it for reasons related to potential pregnancy complications or genetic conditions. This technology is sometimes referred to as fertility therapy or medically assisted reproduction.

Despite its benefits, accessing ART can be challenging for many due to its high costs and limited coverage by private insurance plans. While ART offers hope to those dealing with infertility, it also raises public health concerns, as evidenced by the increased incidence of multiple births, preterm births, and low birth weights linked to these procedures. One way to mitigate these risks is by regulating the number of embryos that are implanted during treatment.

Monitoring the implications of reproductive technologies like ART, along with contraception methods, has become an essential component of public health initiatives.

FutureWise Market Research has published a report that provides an insightful analysis of Assisted Reproductive Technology Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=2292&type=requestsample

Assisted Reproductive Technology Market Segmentation:

By Procedure

• Fresh donor
• Fresh Non-donor
• Frozen Donor
• Frozen Nondonor
• Embryo/Egg Banking

By Technology

• In-vitro fertilization (IVF)
  • IVF with Intracytoplasmic Sperm Injection (ICSI)
  • IVF without Intracytoplasmic Sperm Injection (ICSI)
• Artificial Insemination - Intrauterine Insemination (AI-IUI)
• Frozen Embryo Replacement (FER)
• Ovulation Induction (OI)
• Donor Conception
• Gamete Intrafallopian Transfer (GIFT)
• Preimplantation Genetic Diagnosis (PGD)
• Surrogacy

By Diagnosis

• Ovulation Testing
• Hysterosalpingography
• Ovarian Reserve Testing
• Genetic Testing
• Other hormone testing
• Imaging tests

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers
• Gynecology Centers
• Feminist Health Centers
• IVF Centers

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Assisted Reproductive Technology Market:

• Thermo Fisher Scientific, Inc.
• Genea Limited
• Cook Medical
• Nidacon International AB
• OvaScience Inc.
• Vitro Life
• Cooper Surgical Inc.
• Merck
• IVFtech ApS
• Irvine scientific
• Hamilton Thorne 
• Cosmos Biomedical
• Microm UK Ltd.
• Origio
• Cryolab Ltd.
• Parallabs
• European Sperm Bank
• Bloom IVF Centre
• Ferring Pharmaceuticals

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=2292&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Assisted Reproductive Technology Market By Procedure, By Technology, By Diagnosis, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com